Investor Presentaiton

17 Venus-PowerX On December 2021, Venus-PowerX completed its First-in-Man clinical trial at West China Hospital of Sichuan University. 全释放全回收 InVision Feature ➤ Self-expanding TAVR ➤ Active anti-paravalvular leak technology ➤ Dry tissue for storage and reduced glutaraldehyde ➤ Anti-calcification technology, long-term durability ➤ 100% retrieving R 启明医疗® VENUSMEDTECH

View entire presentation